Published in Mol Cell Biol on January 01, 1999
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet (2005) 2.92
Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol Cell Biol (2000) 2.79
Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol (1999) 2.09
The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol (1999) 2.01
Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc Natl Acad Sci U S A (1999) 2.00
Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J Virol (2000) 1.97
Centrobin: a novel daughter centriole-associated protein that is required for centriole duplication. J Cell Biol (2005) 1.73
Papillomavirus E6 proteins. Virology (2008) 1.70
E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J Virol (2001) 1.58
Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev (2004) 1.50
The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol (2010) 1.49
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc Natl Acad Sci U S A (2001) 1.47
Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein. Proc Natl Acad Sci U S A (2000) 1.38
Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol Cell Biol (2002) 1.38
Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J Virol (2004) 1.35
Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J Virol (2000) 1.34
Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J Virol (2007) 1.34
Mechanisms of G2 arrest in response to overexpression of p53. Mol Biol Cell (1999) 1.33
Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol Cell Biol (2000) 1.24
Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology (2012) 1.23
Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells. J Virol (2001) 1.23
A Wnt-CKIvarepsilon-Rap1 pathway regulates gastrulation by modulating SIPA1L1, a Rap GTPase activating protein. Dev Cell (2007) 1.22
Papillomavirus E6 oncoproteins. Virology (2013) 1.21
Cellular binding partners of the human papillomavirus E6 protein. Arch Virol (2008) 1.21
RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc Natl Acad Sci U S A (2006) 1.17
The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase. J Virol (2005) 1.17
Downregulation of Rap1GAP contributes to Ras transformation. Mol Cell Biol (2007) 1.16
A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo. J Virol (2002) 1.15
The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity. J Virol (2007) 1.11
Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol (2004) 1.10
Gps2, a protein partner for human papillomavirus E6 proteins. J Virol (2001) 1.09
Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells. J Virol (2003) 1.08
Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci (2010) 1.05
Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. Mol Cell Biol (2010) 1.03
Loss of Rap1GAP in papillary thyroid cancer. J Clin Endocrinol Metab (2008) 1.02
Interaction of zyxin, a focal adhesion protein, with the e6 protein from human papillomavirus type 6 results in its nuclear translocation. J Virol (2001) 1.01
The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability. J Virol (2009) 1.00
Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. Arch Virol (2006) 1.00
Pitx2a binds to human papillomavirus type 18 E6 protein and inhibits E6-mediated P53 degradation in HeLa cells. J Biol Chem (2005) 0.96
The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose. Cell Death Differ (2005) 0.94
Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP. J Virol (2000) 0.93
Functional genetic screen for genes involved in senescence: role of Tid1, a homologue of the Drosophila tumor suppressor l(2)tid, in senescence and cell survival. Mol Cell Biol (2004) 0.92
The ability of GAP1IP4BP to function as a Rap1 GTPase-activating protein (GAP) requires its Ras GAP-related domain and an arginine finger rather than an asparagine thumb. Mol Cell Biol (2009) 0.91
The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins. J Virol (2003) 0.89
BRCA2 suppresses cell proliferation via stabilizing MAGE-D1. Cancer Res (2005) 0.87
Evolution of human papillomavirus carcinogenicity. Adv Virus Res (2010) 0.83
Oncogenes and RNA splicing of human tumor viruses. Emerg Microbes Infect (2014) 0.82
Biomarkers in cervical cancer. Biomark Insights (2007) 0.81
Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells. Endocr Relat Cancer (2011) 0.81
Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways. Viruses (2015) 0.79
Research resource: identification of novel coregulators specific for thyroid hormone receptor-β2. Mol Endocrinol (2013) 0.78
Testing for Ancient Selection Using Cross-population Allele Frequency Differentiation. Genetics (2015) 0.78
Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats. Biol Open (2016) 0.75
Amnion as a surrogate tissue reporter of the effects of maternal preeclampsia on the fetus. Clin Epigenetics (2016) 0.75
Breast cancer subtypes: two decades of journey from cell culture to patients. Adv Exp Med Biol (2011) 0.75
RAP1 GTPase overexpression is associated with cervical intraepithelial neoplasia. PLoS One (2015) 0.75
HPV16 E6 upregulates Aurora A expression. Oncol Lett (2016) 0.75
Roles of Rap1 signaling in tumor cell migration and invasion. Cancer Biol Med (2017) 0.75
Mammalian ECD protein is a novel negative regulator of the PERK arm of unfolded protein response. Mol Cell Biol (2017) 0.75
Comparative expression study of sipa family members during early Xenopus laevis development. Dev Genes Evol (2016) 0.75
p53, the cellular gatekeeper for growth and division. Cell (1997) 31.04
A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (1996) 27.61
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci U S A (1991) 15.52
A gene map of the human genome. Science (1996) 14.32
Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science (1990) 12.88
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell (1993) 12.41
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98
The ubiquitin-proteasome proteolytic pathway. Cell (1994) 9.75
The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol (1989) 8.68
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J (1989) 7.69
Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell (1993) 7.59
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J (1989) 6.60
A ras-related gene with transformation suppressor activity. Cell (1989) 5.81
A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J (1991) 5.39
Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol (1987) 5.00
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature (1992) 4.42
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res (1996) 4.14
Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol Cell Biol (1993) 4.04
cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell (1997) 3.93
Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J Virol (1988) 3.54
In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res (1996) 3.50
Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci U S A (1990) 3.40
Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A (1997) 3.37
36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res (1991) 2.96
Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol (1993) 2.91
Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc Natl Acad Sci U S A (1997) 2.87
Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J (1987) 2.84
Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol (1989) 2.64
The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol (1996) 2.57
Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J Biol Chem (1995) 2.55
The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem (1997) 2.42
Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol (1990) 2.40
PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays (1997) 2.39
Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci U S A (1994) 2.38
Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1. Cell (1991) 2.26
Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science (1995) 2.20
Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J Virol (1991) 2.14
Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor. J Biol Chem (1996) 2.14
Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product. Science (1990) 2.09
Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen. Mol Cell Biol (1997) 2.01
The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci U S A (1997) 2.00
Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol Cell Biol (1992) 1.66
Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc Natl Acad Sci U S A (1995) 1.64
Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. Segregate expression profiles from a rap1GAP gene product. J Biol Chem (1997) 1.54
Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc Natl Acad Sci U S A (1996) 1.54
Inhibition of the ras p21 GTPase-activating protein-stimulated GTPase activity of c-Ha-ras p21 by smg p21 having the same putative effector domain as ras p21s. J Biol Chem (1990) 1.47
Mitogenic and oncogenic properties of the small G protein Rap1b. Proc Natl Acad Sci U S A (1998) 1.40
Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res (1995) 1.33
Localization of the rap1GAP catalytic domain and sites of phosphorylation by mutational analysis. Mol Cell Biol (1992) 1.29
Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene. Proc Natl Acad Sci U S A (1997) 1.25
Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J Virol (1996) 1.24
Molecular cloning of a novel mitogen-inducible nuclear protein with a Ran GTPase-activating domain that affects cell cycle progression. Mol Cell Biol (1995) 1.24
Gene in the region of the Friedreich ataxia locus encodes a putative transmembrane protein expressed in the nervous system. Proc Natl Acad Sci U S A (1993) 1.10
Mutant p53-induced immortalization of primary human mammary epithelial cells. Cancer Res (1996) 1.02
Papillomaviruses in human cancer. Appl Pathol (1987) 0.99
Phosphorylation of rap1GAP in vivo and by cAMP-dependent kinase and the cell cycle p34cdc2 kinase in vitro. J Biol Chem (1992) 0.99
Biological characterization of Drosophila Rapgap1, a GTPase activating protein for Rap1. Proc Natl Acad Sci U S A (1997) 0.97
Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus. Oncogene (1997) 0.93
Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells. Cancer Res (1997) 0.92
Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas. Hum Pathol (1997) 0.90
UMLS knowledge for biomedical language processing. Bull Med Libr Assoc (1993) 15.05
Lexical methods for managing variation in biomedical terminologies. Proc Annu Symp Comput Appl Med Care (1994) 13.38
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature (1997) 10.14
Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science (1994) 6.65
Automated access to a large medical dictionary: online assistance for research and application in natural language processing. Comput Biomed Res (1990) 6.64
E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res (1996) 4.14
Discovering missed synonymy in a large concept-oriented Metathesaurus. Proc AMIA Symp (2000) 3.39
Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res (1991) 3.24
Evidence-based National Vaccine Policy. Indian J Med Res (2010) 2.75
Rheumatic fever and rheumatic heart disease: primary prevention is the cost effective option. Indian J Pediatr (2007) 2.28
Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science (1995) 2.20
The case against 'the case against childhood cholesterol screening'. JAMA (1991) 2.17
Cloning of human and bovine homologs of SNF2/SWI2: a global activator of transcription in yeast S. cerevisiae. Nucleic Acids Res (1992) 2.14
Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol (1999) 2.09
The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J (1995) 2.05
Transcatheter closure of post-myocardial infarction ventricular septal defect with Amplatzer septal occluder. Catheter Cardiovasc Interv (2001) 1.93
Survey of transposable elements from rice genomic sequences. Plant J (2001) 1.92
Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc Natl Acad Sci U S A (1990) 1.81
Nonneutral evolution at the mitochondrial NADH dehydrogenase subunit 3 gene in mice. Proc Natl Acad Sci U S A (1994) 1.77
Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7. Proc Natl Acad Sci U S A (1995) 1.64
FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J (1995) 1.61
Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J (1994) 1.52
Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells. Cancer Res (1988) 1.52
Cryptococcus albidus meningitis. J Infect (1980) 1.48
Rapid assessment of mycobacterial growth inside macrophages and mice, using the radiometric (BACTEC) method. Tuber Lung Dis (1994) 1.48
Pharmacology of ceftizoxime compared with that of cefamandole. Antimicrob Agents Chemother (1981) 1.46
The tricarboxylic acid cycle of Helicobacter pylori. Eur J Biochem (1999) 1.44
The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord (2004) 1.41
Structural characteristics of CD40 ligand that determine biological function. Semin Immunol (1994) 1.41
Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers. Antimicrob Agents Chemother (1981) 1.38
Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: a case for aggressive therapy to the tumor bearing quadrant. Int J Radiat Oncol Biol Phys (1993) 1.38
Slime production, adherence and hydrophobicity in coagulase-negative staphylococci causing peritonitis in peritoneal dialysis. J Hosp Infect (1997) 1.38
Comparative pharmacokinetics of cefoperazone and cefamandole. Antimicrob Agents Chemother (1981) 1.35
Blockade of adenosine A2B receptors ameliorates murine colitis. Br J Pharmacol (2008) 1.35
Processing of the Drosophila Sog protein creates a novel BMP inhibitory activity. Development (2000) 1.35
DSS1 is required for the stability of BRCA2. Oncogene (2006) 1.35
Mutant G protein alpha subunit activated by Gbeta gamma: a model for receptor activation? Proc Natl Acad Sci U S A (2001) 1.32
Mitochondrial DNA variation and the evolution of Robertsonian chromosomal races of house mice, Mus domesticus. Genetics (1994) 1.32
HIV risk among homosexual, bisexual, and heterosexual male and female youths. Arch Sex Behav (1999) 1.31
Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent. Oncogene (1995) 1.31
Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J Biol Chem (1996) 1.29
Perinatal mortality-incidence and effect of various maternal factors, Part I. Indian J Pediatr (1982) 1.28
Genetic analysis of viable Hsp90 alleles reveals a critical role in Drosophila spermatogenesis. Genetics (1999) 1.28
Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene. J Clin Invest (1999) 1.28
The role of electrochemical surface properties in thrombosis at vascular interfaces: cumulative experience of studies in animals and man. Bull N Y Acad Med (1972) 1.27
Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil (2010) 1.26
Relation of abdominal height to cardiovascular risk factors in young adults: the Bogalusa heart study. Am J Epidemiol (2000) 1.25
An approach to computer-aided inhibitor design: application to cathepsin L. J Comput Aided Mol Des (1992) 1.25
Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J Virol (1996) 1.24
Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells. Proc Natl Acad Sci U S A (1990) 1.24
Nosocomial multiply resistant Providencia stuartii: a long-term outbreak with multiple biotypes and serotypes at one hospital. J Clin Microbiol (1980) 1.24
Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells. J Virol (2001) 1.23
Structural basis of C3b binding by glycoprotein C of herpes simplex virus. J Virol (1992) 1.23
The role for NES1 serine protease as a novel tumor suppressor. Cancer Res (1998) 1.23
Diabetes and the enteric nervous system. Neurogastroenterol Motil (2007) 1.19
CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model. Am J Transplant (2011) 1.18
Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle. Infect Immun (1999) 1.18
The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int J Radiat Oncol Biol Phys (1995) 1.18
Timing of HIV interventions on reductions in sexual risk among adolescents. Am J Community Psychol (1998) 1.16
The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants. Oncogene (2009) 1.16
Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance. Cell Mol Life Sci (2006) 1.15
Antibodies to Cag A protein are not predictive of serious gastroduodenal disease in Indian patients. Indian J Gastroenterol (1998) 1.13
Analysis of nitrite reductase (nirK and nirS) genes and cultivation reveal depauperate community of denitrifying bacteria in the Black Sea suboxic zone. Environ Microbiol (2007) 1.12
Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. Int J Radiat Oncol Biol Phys (1989) 1.12
Japanese encephalitis in India: an overview. Indian J Pediatr (2004) 1.12
Evaluation of microbicidal activity of a new disinfectant: Sterilox 2500 against Clostridium difficile spores, Helicobacter pylori, vancomycin resistant Enterococcus species, Candida albicans and several Mycobacterium species. J Hosp Infect (1999) 1.11
Modulation of the baboon (Papio anubis) uterine endometrium by chorionic gonadotrophin during the period of uterine receptivity. Proc Natl Acad Sci U S A (1999) 1.10
Multiple organ dysfunction syndrome following single wasp sting. Indian J Pediatr (2007) 1.09
Modeling protein loops using a phi i + 1, psi i dimer database. Protein Sci (1995) 1.09
Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions. Neurogastroenterol Motil (2014) 1.09
Japanese encephalitis in and around Pondicherry, South India: a clinical appraisal and prognostic indicators for the outcome. J Trop Pediatr (2003) 1.08
Molecular mechanisms for the antiapoptotic action of gastrin. Am J Physiol Gastrointest Liver Physiol (2001) 1.07
The relation of atherosclerotic lesions to antemortem and postmortem lipid levels: the Bogalusa Heart Study. Atherosclerosis (1993) 1.07
Blinded rechecking of sputum smears for acid-fast bacilli to ensure the quality and usefulness of restaining smears to assess false-positive errors. Int J Tuberc Lung Dis (2003) 1.07
Absorbable or non-absorbable sutures? A prospective, randomised evaluation of aesthetic outcomes in patients undergoing elective day-case hand and wrist surgery. Ann R Coll Surg Engl (2010) 1.07
Ligands for the receptor tyrosine kinases hek and elk: isolation of cDNAs encoding a family of proteins. Oncogene (1995) 1.07
Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP). J Med Chem (1998) 1.06
Persistent diarrhea: risk factors and outcome. Indian J Pediatr (2010) 1.05
The association of birth weight with developmental trends in blood pressure from childhood through mid-adulthood: the Bogalusa Heart study. Am J Epidemiol (2007) 1.05
Identification and characterization of golgin-84, a novel Golgi integral membrane protein with a cytoplasmic coiled-coil domain. J Biol Chem (1999) 1.05
PKN binds and phosphorylates human papillomavirus E6 oncoprotein. J Biol Chem (2000) 1.04
Characteristics of the human heart: design requirements for replacement. Trans Am Soc Artif Intern Organs (1971) 1.04
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase. J Med Chem (2000) 1.03
Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res (1996) 1.03
Interleukin-1 receptor (IL-1R) liquid formulation development using differential scanning calorimetry. Pharm Res (1998) 1.03
Obesity and its associated disease: a role for microbiota? Neurogastroenterol Motil (2012) 1.03
Subinternal limiting membrane and subhyaloid haemorrhage in Terson syndrome: the macular 'double ring' sign. Eye (Lond) (2005) 1.03
Effect of transforming growth factor alpha and interleukin 8 on somatostatin release from canine fundic D cells. Gastroenterology (1997) 1.02
A brief HIV intervention for adolescents and young adults. Am J Orthopsychiatry (1998) 1.02
Mutant p53-induced immortalization of primary human mammary epithelial cells. Cancer Res (1996) 1.02